Skip to content
value.today

SiteOne Therapeutics, Inc.

🇺🇸 Bozeman, Montana, USAPharmaceuticalsFounded 2014
Total raised
$16 M
2 rounds on record
Latest round
$15 M
Dec 2016
First round on record
Jul 2015
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of SiteOne Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2016$15 MNo. 2$10 to $50 million

SiteOne Therapeutics, Inc.: Raise no. 2, Dec 2016

Investors in this round

19 investors had bought by the notice of Feb 14, 2017: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John E. Mulcahy · Executive Officer
  • Stan E. Abel · Executive Officer, Director
  • Joseph E. Zakrzewski · Director
  • Justin E. Du Bois · Director
  • Lowell E. Sears · Director
  • Rick E. Orr · Director
  • Will E. Price · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stan E. Abel, Ceo. Newest notice filed Feb 14, 2017. Read the notice at the SEC.

equitySEC
Jul 2015$1 MNo. 1Under $2 million

SiteOne Therapeutics, Inc.: Raise no. 1, Jul 2015

Investors in this round

13 investors had bought by the notice of Jul 16, 2015: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • George Miljanich · Executive Officer
  • Stan Abel · Executive Officer, Director
  • Joseph Zakrzewski · Director
  • Justin DuBois · Director
  • Lowell Sears · Director
  • Rick Orr · Director
  • Will Price · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stan Abel, Ceo. Newest notice filed Jul 16, 2015. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • SiteOne Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2017).

    SEC Form D · Feb 2017

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Feb 2017

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of SiteOne Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by SiteOne Therapeutics, Inc.
NameRoleNamed in
John E. MulcahyExecutive officerFeb 2017
Stan E. AbelExecutive officerFeb 2017
George MiljanichExecutive officerJul 2015
Stan AbelExecutive officerJul 2015
Joseph E. ZakrzewskiDirectorFeb 2017
Justin E. Du BoisDirectorFeb 2017
Lowell E. SearsDirectorFeb 2017
Rick E. OrrDirectorFeb 2017
Stan E. AbelDirectorFeb 2017
Will E. PriceDirectorFeb 2017
Joseph ZakrzewskiDirectorJul 2015
Justin DuBoisDirectorJul 2015
Lowell SearsDirectorJul 2015
Rick OrrDirectorJul 2015
Stan AbelDirectorJul 2015
Will PriceDirectorJul 2015